How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 22 10 2019
pubmed: 4 1 2020
medline: 3 2 2021
entrez: 4 1 2020
Statut: ppublish

Résumé

Recently, it was reported that minimally invasive surgery (MIS) has a negative impact on early-stage cervical cancer (ECC) patient survival. At the same time, advantages of MIS regarding quality of life and low rate of intra- and postoperative complications are well known. Therefore, it is essential to select patients who may benefit from MIS without worsening their oncologic outcomes. The aim of this study is to investigate which pathological factors could guide surgeons' choice about the best approach in ECC. Patients with 2009 FIGO stage from IA1 with lymphovascular space invasion (LVSI) to IB1/IIA1 treated by open or laparoscopic surgery were judged eligible for the study. Disease-free survivals (DFS) of both approaches were tested in subgroups, defined according to histology, tumor size, grading, LVSI, parametrial involvement, and nodal status. A total of 423 patients were enrolled (217 in the open and 206 in the laparoscopic group). No difference between open surgery and laparoscopy was found among subgroups defined according to histology, grading, LVSI, parametrial involvement, or nodal status. Among patients with tumor > 20 mm, laparoscopy showed a significantly higher relapse risk [hazard ratio (HR): 2.103, p = 0.030]. Among patients with tumor < 20 mm, laparoscopy showed DFS superimposable to open surgery (HR: 0.560, p = 0.128). Tumor size of 20 mm appeared as the only independent discrimination criterion in patients whose prognosis is affected by surgical approaches.

Sections du résumé

BACKGROUND BACKGROUND
Recently, it was reported that minimally invasive surgery (MIS) has a negative impact on early-stage cervical cancer (ECC) patient survival. At the same time, advantages of MIS regarding quality of life and low rate of intra- and postoperative complications are well known. Therefore, it is essential to select patients who may benefit from MIS without worsening their oncologic outcomes. The aim of this study is to investigate which pathological factors could guide surgeons' choice about the best approach in ECC.
PATIENTS AND METHODS METHODS
Patients with 2009 FIGO stage from IA1 with lymphovascular space invasion (LVSI) to IB1/IIA1 treated by open or laparoscopic surgery were judged eligible for the study. Disease-free survivals (DFS) of both approaches were tested in subgroups, defined according to histology, tumor size, grading, LVSI, parametrial involvement, and nodal status.
RESULTS RESULTS
A total of 423 patients were enrolled (217 in the open and 206 in the laparoscopic group). No difference between open surgery and laparoscopy was found among subgroups defined according to histology, grading, LVSI, parametrial involvement, or nodal status. Among patients with tumor > 20 mm, laparoscopy showed a significantly higher relapse risk [hazard ratio (HR): 2.103, p = 0.030]. Among patients with tumor < 20 mm, laparoscopy showed DFS superimposable to open surgery (HR: 0.560, p = 0.128).
CONCLUSIONS CONCLUSIONS
Tumor size of 20 mm appeared as the only independent discrimination criterion in patients whose prognosis is affected by surgical approaches.

Identifiants

pubmed: 31898100
doi: 10.1245/s10434-019-08162-5
pii: 10.1245/s10434-019-08162-5
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1947-1955

Références

Bansal N, Herzog TJ, Shaw RE, et al. Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obs Gynecol. 2009;201(5):485.e1–9. https://doi.org/10.1016/j.ajog.2009.06.015
doi: 10.1016/j.ajog.2009.06.015
National Comprehensive Cancer Network. Cervical Cancer (Version 4.2019). https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf . Accessed 30 April 2019
Nezhat CR, Burrell MO, Nezhat FR, Benigno BB, Welander CE. Laparoscopic radical hysterectomy with paraaortic and pelvic node dissection. Am J Obstet Gynecol. 1992;166(3):864–5. https://doi.org/10.1016/0002-9378(92)91351-a
doi: 10.1016/0002-9378(92)91351-A pubmed: 1532291
Diver E, Hinchcliff E, Gockley A, et al. Minimally invasive radical hysterectomy for cervical cancer is associated with reduced morbidity and similar survival outcomes compared with laparotomy. J Minim Invasive Gynecol. 2017;24(3):402–6. https://doi.org/10.1016/j.jmig.2016.12.005
doi: 10.1016/j.jmig.2016.12.005 pubmed: 28011096
Nam JH, Park JY, Kim DY, et al. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol. 2012;23(4):903–11. https://doi.org/10.1093/annonc/mdr360
doi: 10.1093/annonc/mdr360 pubmed: 21841155
Corrado G, Vizza E, Legge F, et al. Comparison of different surgical approaches for stage IB1 cervical cancer patients: a multi-institution study and a review of the literature. Int J Gynecol Cancer. 2018;28(5):1020–8. https://doi.org/10.1097/igc.0000000000001254
doi: 10.1097/IGC.0000000000001254 pubmed: 29727351
Laterza RM, Uccella S, Casarin J, et al. Recurrence of early stage cervical cancer after laparoscopic versus open radical surgery. Int J Gynecol Cancer. 2016;26(3):47–52. https://doi.org/10.1097/igc.0000000000000627
doi: 10.1097/IGC.0000000000000627 pubmed: 26807638
Colombo N, Preti E, Landoni F, et al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(suppl_6):vi33–8. https://doi.org/10.1093/annonc/mdt353
doi: 10.1093/annonc/mdt353
Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Eng J Med. 2018;379(20):1895–904
doi: 10.1056/NEJMoa1806395 pubmed: 30380365
Kimmig R, Ind T. Minimally invasive surgery for cervical cancer: consequences for treatment after LACC Study. J Gynecol Oncol. 2018;29(4):e75. https://doi.org/10.3802/jgo201829.e75
doi: 10.3802/jgo.2018.29.e75
Naumann RW. Minimally invasive radical hysterectomy has many benefits compared with open radical hysterectomy: will the LACC trial cause the premature demise of this procedure? J Minim Invasive Gynecol. 2019;26(3):379–80. https://doi.org/10.1016/j.jmig.2019.01.002
doi: 10.1016/j.jmig.2019.01.002 pubmed: 30639317
Leitao MM Jr. The LACC trial: Has minimally invasive surgery for early-stage cervical cancer been dealt a knockout punch? Int J Gynecol Cancer. 2018;28(7):1248–50
doi: 10.1097/IGC.0000000000001342
Park JY, Nam JH. How should gynecologic oncologists react to the unexpected results of LACC trial? J Gynecol Oncol. 2018;29(4):e74. https://doi.org/10.3802/jgo201829.e74
doi: 10.3802/jgo.2018.29.e74
Margul DJ, Yang J, Seagle BL, et al. Outcomes and costs of open, robotic, and laparoscopic radical hysterectomy for stage IB1 cervical cancer. J Clin Oncol. 2018;36(15_suppl):5502. https://doi.org/10.1200/JCO.2018.36.15_suppl.5502
doi: 10.1200/JCO.2018.36.15_suppl.5502
Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, Yang J, Seagle BL, Alexander A, Barber EL, Rice LW, Wright JD, Kocherginsky M, Shahabi SR-HJ. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 2018;379(20):1905–14
doi: 10.1056/NEJMoa1804923 pubmed: 6464372 pmcid: 6464372
Angst E, Hiatt JR, Gloor B, Reber HA, Hines OJ. Laparoscopic surgery for cancer: a systematic review and a way forward. J Am Coll Surg. 2010;211(3):412–23. https://doi.org/10.1016/j.jamcollsurg.2010.05.019.laparoscopic
doi: 10.1016/j.jamcollsurg.2010.05.019.Laparoscopic pubmed: 2930894 pmcid: 2930894
Kooby DA. Laparoscopic surgery for cancer: historical, theoretical, and technical considerations. Oncol (willist Park). 2006;20(8):917–27
Alletti SG, Petrillo M, Vizzielli G, Bottoni C, Nardelli F, Costantini B, Quagliozzi L, Gallotta V, Scambia G, Fagotti A. Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: a single-institution retrospective case-control study. Gynecol Oncol. 2016;143(3):516–520
doi: 10.1016/j.ygyno.2016.10.017
Gioiella ME, Berkman B, Robinson M. Spirituality and quality of life in gynecologic oncology patients. Cancer Pract. 1998;6(6):333–8. https://doi.org/10.1046/j.1523-5394.1998.006006333.x
doi: 10.1046/j.1523-5394.1998.006006333.x
Zeng YC, Ching SS, Loke AY. Quality of life measurement in women with cervical cancer: implications for Chinese cervical cancer survivors. Heal Qual Life Outcomes. 2010;19:830
Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obs. 2009;105(2):107–8
doi: 10.1016/j.ijgo.2009.02.009
Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9(3):297–303
doi: 10.1016/S1470-2045(08)70074-3 pubmed: 18308255 pmcid: 18308255
Kaplan EL, Meier P. Nonparametric estimation from incomplete samples. J Am Stat Assoc. 1958;53(282):457–81
doi: 10.1080/01621459.1958.10501452
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50(3):163–70
pubmed: 5910392
Cox DR. Models and Life-Tables Regression. J R Stat Soc Ser B (Methodological). 1972;34(2):187–220
Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Laparoscopic compared with open radical hysterectomy in obese women with early-stage cervical cancer. Obs Gynecol. 2012;119(6):1201–9
doi: 10.1097/AOG.0b013e318256ccc5
Shah CA, Veljovich D, Paley P, Beck T, Liao JB, Giannakopoulos N V. Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer. J Gynecol Oncol. 2017;28(6):e82
doi: 10.3802/jgo.2017.28.e82
Wang YZ, Deng L, Xu HC, Zhang Y, Liang, ZQ. Laparoscopy versus laparotomy for the management of early stage cervical cancer. BMC Cancer. 2015. https://doi.org/10.1186/s12885-015-1818-4
Kim SI, Cho JH, Seol A, et al. Gynecologic oncology comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1–IIA2 cervical cancer. Gynecol Oncol. 2019;153(1):3–12
doi: 10.1016/j.ygyno.2019.01.008 pubmed: 30642625
Wagner AE, Pappas L, Ghia AJ, Gaffney DK. Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions. Gynecol Oncol. 2013;129(3):517–21
doi: 10.1016/j.ygyno.2013.03.008 pubmed: 23528928
Fagotti A, Pedone Anchora L, Conte C, et al. Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients. Cancer Med. 2016;5(8):1725–30. https://doi.org/10.1002/cam4.722
doi: 10.1002/cam4.722 pubmed: 27230108 pmcid: 4971900
Ramirez PT, Pareja R, Rendón GJ, Millan C, Frumovitz M, Schmeler KM. Management of low-risk early-stage cervical cancer: Should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol. 2014;132(1):254–9. https://doi.org/10.1016/j.ygyno.2013.09.004
doi: 10.1016/j.ygyno.2013.09.004 pubmed: 24041877
Kohler C, Hertel H, Herrmann J, et al. Laparoscopic radical hysterectomy with consequent transvaginal closure of vaginal cuff: results of a retrospective analysis of a prospective collected multicenter database. Int J Gynecol Cancer. 2019. https://doi.org/10.1136/ijgc-2019-000388
doi: 10.1136/ijgc-2019-000388
Mabuchi S, Okazawa M, Matsuo K, et al. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma. Gynecol Oncol. 2012;127(1):114–20. https://doi.org/10.1016/j.ygyno.2012.06.021
doi: 10.1016/j.ygyno.2012.06.021

Auteurs

Luigi Pedone Anchora (L)

Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy. luigi.us@hotmail.it.

Luigi Calrlo Turco (LC)

Division of Gynecologic Oncology, Fondazione di Ricerca e Cura Giovanni Paolo II, Università Cattolica del Sacro Cuore, Campobasso, Italy.

Nicolò Bizzarri (N)

Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy.

Vito Andrea Capozzi (VA)

Department of Gynecology and Obstetrics, University of Parma, Parma, Italy.

Andrea Lombisani (A)

Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy.

Vito Chiantera (V)

Department of Gynecologic Oncology, University of Palermo, Palermo, Italy.

Francesca De Felice (F)

Department of Radiotherapy, Policlinico Umberto I 'Sapienza', University of Rome, Rome, Italy.

Valerio Gallotta (V)

Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy.

Francesco Cosentino (F)

Division of Gynecologic Oncology, Fondazione di Ricerca e Cura Giovanni Paolo II, Università Cattolica del Sacro Cuore, Campobasso, Italy.

Anna Fagotti (A)

Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy.

Gabriella Ferrandina (G)

Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy.

Giovanni Scambia (G)

Department of Obstetrics and Gynecology, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH